» Articles » PMID: 17676931

Surface Structure of Amyloid-beta Fibrils Contributes to Cytotoxicity

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2007 Aug 7
PMID 17676931
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Amyloid beta (Abeta) toxicity has been hypothesized to initiate the pathogenesis of Alzheimer's disease (AD). The characteristic fibrillar morphology of Abeta-aggregates, that constitute the main components of senile plaque, has long been considered to account for the neurotoxicity. But recent reports argue against a primary role for mature fibrils in AD pathogenesis because of the lack of a robust correlation between the severity of neurological impairment and the extent of amyloid deposition. Toxicity from the soluble prefibrillar intermediate entity of aggregates often called oligomer has recently proposed a plausible explanation for this inconsistency. An alternative explanation is based on the observation that certain amyloid fibril morphologies are more toxic than others, indicating that not all amyloid fibrils are equally toxic. Here, we report that it is not only the beta-sheeted fibrillar structure but also the surface physicochemical composition that affects the toxicity of Abeta fibrils. For the first time, colloidal gold was used to visualize by electron microscopy positive-charge clusters on Abeta fibrils. Chemical modifications as well as point-mutated Abeta synthesis techniques were applied to change the surface structures of Abeta and to show how local structure affects surface properties that are responsible for electrostatic and hydrophobic interactions with cells. We also report that covering the surface of Abeta fibers with myelin basic protein, which has surface properties contrary to those of Abeta, suppresses Abeta toxicity. On the basis of these results, we propose that the surface structure of Abeta fibrils plays an important role in Abeta toxicity.

Citing Articles

Inhibition of cytotoxic self-assembly of HEWL through promoting fibrillation by new synthesized α-hydroxycarbamoylphosphinic acids.

Mahdavimehr M, Kaboudin B, Alaie S, Tondkar F, Eshkaftaki Z, Ebrahim-Habibi M RSC Adv. 2024; 14(42):31227-31242.

PMID: 39355328 PMC: 11443501. DOI: 10.1039/d4ra02969k.


Modulation of Alzheimer's Disease Aβ40 Fibril Polymorphism by the Small Heat Shock Protein αB-Crystallin.

Rodina N, Hornung S, Sarkar R, Suladze S, Peters C, Schmid P J Am Chem Soc. 2024; 146(28):19077-19087.

PMID: 38973199 PMC: 11258688. DOI: 10.1021/jacs.4c03504.


In Situ Raman Study of Neurodegenerated Human Neuroblastoma Cells Exposed to Outer-Membrane Vesicles Isolated from .

Pezzotti G, Adachi T, Imamura H, Bristol D, Adachi K, Yamamoto T Int J Mol Sci. 2023; 24(17).

PMID: 37686157 PMC: 10488263. DOI: 10.3390/ijms241713351.


Microglia-Astrocyte Communication in Alzheimer's Disease.

Wu Y, Eisel U J Alzheimers Dis. 2023; 95(3):785-803.

PMID: 37638434 PMC: 10578295. DOI: 10.3233/JAD-230199.


Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer's Disease.

Moreira D, Santos S, Leiro V, Pego A Pharmaceutics. 2023; 15(4).

PMID: 37111540 PMC: 10140951. DOI: 10.3390/pharmaceutics15041054.